Collegium Pharmaceutical, Inc. COLL Nucynta Products — Cost

Other product segments

Similar metrics at other companies

BBIONet product revenue — Cost of Revenue

$7.73M+280%

ABTNutritional Products — Cost of products sold, excluding amortization of intangible assets

$1.09B-3.1%

KMBNA — Cost of products sold

$1.58B+1.2%

ARDXProduct sales, net — Cost of Sales

$2.88M+22.9%

TVTXTotal net product sales — Cost of goods sold

$1.95M+55.6%

LEUProduct — Cost of Sales

$16.7M-16.9%

Questions, answered.

What is Collegium Pharmaceutical, Inc.'s nucynta products — cost?

Collegium Pharmaceutical, Inc. (COLL) reported nucynta products — cost of $521.17M in Q1 2026.

How has Collegium Pharmaceutical, Inc.'s nucynta products — cost changed year-over-year?

Collegium Pharmaceutical, Inc.'s nucynta products — cost decreased by 0.0% year-over-year, from $521.17M to $521.17M.

What is the long-term trend for Collegium Pharmaceutical, Inc.'s nucynta products — cost?

Over 3 years (2022 to 2025), Collegium Pharmaceutical, Inc.'s nucynta products — cost has grown at a 0.0% compound annual growth rate (CAGR), from $2.08B to $2.08B.

What does nucynta products — cost mean?

Represents the total direct and indirect costs associated with the production, distribution, and support of the Nucynta product line. This metric is essential for evaluating the gross margin and overall profitability of the specific pharmaceutical product segment.